Market Trends of Brazil Bariatric Surgery Industry
Closure Device is Expected to Witness a High Significant Growth in the Assisting Device Segment
The closure devices segment is poised for substantial growth as bariatric surgeries become increasingly common, mirroring broader market trends. Closure devices are pivotal in bariatric surgeries, ensuring the safe execution of these procedures. They are also vital for reconnecting tissues and closing incisions during laparoscopic surgeries, especially for obese patients.
Closure devices are essential in sealing port sites from laparoscopic procedures in bariatric surgeries. They efficiently and safely close small incisions, minimizing complications like infections or hernias. As minimally invasive techniques gain traction, the demand for these effective closure devices is projected to surge.
For instance, in April 2024, the Hospital das Clínicas at the Federal University of Pernambuco launched a bariatric surgery campaign for World Obesity Day, treating 12 patients with severe obesity. Such efforts highlight the urgency of tackling obesity and emphasize the rising volume of surgeries, boosting the demand for closure devices.
However, access to bariatric procedures is uneven across Brazil. In 2023, only 0.2% of severely obese Brazilians could undergo surgery via the Unified Health System (SUS). With just 98 facilities authorized for bariatric and metabolic surgeries among Brazil's 7,700 hospitals, service availability is challenging. Notably, four states—Amazonas, Rondônia, Roraima, and Amapá—lack these authorized services, underscoring a significant healthcare accessibility gap.
This limited access could bolster the market for closure devices as facilities aim to enhance surgical offerings and patient outcomes. As more hospitals integrate bariatric surgery programs, the demand for closure devices—crucial for successful surgeries—is set to rise.
Given the uptick in surgeries and the trend towards minimally invasive techniques, Brazil's closure devices segment in the bariatric market is poised for growth. With health campaigns like the one at Hospital das Clínicas driving surgical interventions, the demand for closure devices is expected to escalate. Thus, bridging the access gap in bariatric surgeries is paramount. Expanding surgical service availability nationwide will benefit patient outcomes and stimulate the market for essential technologies like closure devices.
Implantable Devices is Expected to Dominate the Market Over the Forecast Period
Brazil is grappling with a growing obesity epidemic, prompting a surge in demand for effective interventions, particularly in the bariatric surgery market. Among the diverse treatment options, implantable devices, including gastric balloons and gastric bands, are gaining prominence due to their effectiveness and minimally invasive approach. These devices provide patients with a reliable method for weight loss and enhance their overall quality of life.
The rising acceptance of these implantable devices is bolstered by clinical evidence attesting to their effectiveness. With patients and healthcare providers leaning towards safer, less invasive alternatives, the appetite for devices like gastric balloons and bands is set to expand. This trend gains added significance in Brazil, where public health campaigns underscore the urgency of effective obesity management. In March 2023, Brazil introduced a new gastric balloon device, recently approved by the National Health Surveillance Agency (ANVISA). This cutting-edge device was designed to remain in the patient's stomach for four months and aims for a 15% body weight reduction. At a price of R$23,000 (USD 4,056.5), it stood out as a feasible non-surgical avenue for weight loss. While it began its journey in clinics, its broader rollout hints at a growing inclination towards less invasive bariatric solutions catering to a diverse audience.
The significance of gastric bands in the bariatric surgery domain cannot be understated. Insights from the 2023 Brazilian Congress of Bariatric and Metabolic Surgery shed light on the advantages of revisional surgeries. Notably, the removal of gastric bands mitigated complications like dysphagia, enhanced the patient's quality of life, and promoted additional weight loss. Such instances underscore the pivotal role of implantable devices in intricate clinical situations, cementing their value in the market.
Looking ahead, the implantable devices segment in Brazil's bariatric surgery market is set for notable expansion. Technological advancements, rising endorsement from patients and healthcare professionals, and favorable regulatory movements fuel this growth. The debut of innovative solutions, like gastric balloons, signals a broader transition towards efficient and minimally invasive weight loss methods.
